Valuation Trading Multiples & Precedent Transactions: Medical Monitoring and Respiratory Device Companies
Valuation benchmarks for Medical Monitoring and Respiratory Device Companies. Access public trading comps, EV/EBITDA acquisition multiples, and private market data for pitch books and valuation analysis.
1.1 - Medical Monitoring and Respiratory Device Companies Market Context & Valuation Drivers
Companies in this trading comparables group manufacture and supply clinical patient monitoring and respiratory care devices used across acute and ambulatory settings. Their business models combine capital equipment placement with recurring revenue from disposables, software, and service. They are comparable given shared regulatory pathways, hospital procurement dynamics, connectivity to clinical workflows, and similar revenue mix between hardware, consumables, and digital health monitoring platforms.
Typical capabilities span multi-parameter bedside and MRI-safe patient monitors, wearable cardiac patch monitoring, continuous EEG for neurocritical care, ventilators and cloud-connected CPAP therapy, anesthesia delivery workstations, precision infusion pumps and IV systems, single-use bronchoscopes and airway management devices, and remote monitoring platforms with analytics, reporting, and clinician workflows. Many vendors offer interoperability, connectivity, and service contracts supporting device uptime, cybersecurity, and regulatory compliance.
Primary buyers include hospitals and health systems, intensive care and emergency departments, and outpatient sleep therapy providers. Valuation benchmarks emphasize revenue growth, recurring consumables and software mix, product gross margins, and installed base expansion driving pull-through utilization. Additional indicators include service contract attach rates, device replacement cycles, and customer retention across integrated hardware-software ecosystems.
2. Valuation Analysis: Public Trading Comps & Multiples for Medical Monitoring and Respiratory Device Companies companies
2.1 - Public Peer Groups & Median Valuation Multiples for Medical Monitoring and Respiratory Device Companies sector
Comparable group 1: Medical Monitoring and Respiratory Device Companies
Mindray
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of innovative medical devices and solutions focusing on patient monitoring, anesthesia, and ultrasound, aiming to enhance healthcare quality by making advanced healthcare technology accessible worldwide.
- Key Products:
- Patient Monitoring: Advanced systems providing real-time data for effective patient management
- In Vitro Diagnostics: Solutions ranging from hematology, chemistry to molecular diagnostics
- Ultrasound: Advanced imaging solutions for various clinical applications
- Anesthesia: Comprehensive anesthesia systems ensuring patient safety
- Surgical Tables: Ergonomic and versatile operating tables suitable for diverse surgical needs
Jiangsu Yuyue Medical
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of medical devices and home healthcare products, offering solutions for respiratory care, diabetes management, diagnostic devices, and rehabilitation equipment globally
- Key Products:
- Respiratory Solutions: Devices for effective management of respiratory conditions
- Diabetes Management: Innovative tools and monitors for diabetes care
- Medical Diagnostic Devices: Equipment for accurate diagnostic procedures in clinical settings
- Rehabilitation and Mobility: Solutions to aid patient rehabilitation and mobility enhancement
- AEDs: Automated external defibrillators designed for swift emergency responses